Editorial: Exemplifying a Cognitive Science−Driven Approach to Intervention Innovation: Targeting Face Emotion Labeling to Reduce Anger-Proneness in Disruptive Mood Dysregulation Disorder

Disruptive mood dysregulation disorder (DMDD) is a condition in which children or adolescents experience chronically irritable or angry mood. These feelings typically manifest through frequent and intense temper outbursts that can be verbal (eg, yelling) or physical (eg, hitting). These symptoms car...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American Academy of Child and Adolescent Psychiatry Vol. 61; no. 1; pp. 26 - 28
Main Author Lau, Jennifer Y.F.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.01.2022
Elsevier BV
Subjects
Adolescent
Aggression
Anger
Attention Deficit and Disruptive Behavior Disorders - therapy
Bias
Child
Cognition
Cognitive ability
Cognitive bias
Cognitive Psychology
Cognitive Science
Depression (Psychology)
Eating Disorders
Effect Size
Emotions
Evidence-based medicine
Families & family life
Happiness
Hostility
Humans
Information Processing
Innovations
Intervention
Irritability
Irritable Mood
Labeling
Mood
Mood Disorders
Peer Relationship
Peer relationships
Physical symptoms
Post traumatic stress disorder
Posttraumatic Stress Disorder
Psychiatry
Reading Comprehension
Response Style (Tests)
School functioning
Symptoms (Individual Disorders)
Verbal abuse
Young Adults
Youth
Online AccessGet full text

Cover

More Information
Summary:Disruptive mood dysregulation disorder (DMDD) is a condition in which children or adolescents experience chronically irritable or angry mood. These feelings typically manifest through frequent and intense temper outbursts that can be verbal (eg, yelling) or physical (eg, hitting). These symptoms carry a personal cost, affecting family life, peer relationships, and school functioning. Yet, evidence-based treatment options can be difficult to access. A recent therapeutic solution—Cognitive Bias Modification (CBM)—lies in targeting neurocognitive mechanisms known to maintain and contribute to irritability. In this issue, Haller and colleagues use a fast-fail approach (based on a pre-registered study protocol) to evaluate the potential of a new CBM intervention for young people with DMDD. Here, we discuss what work is needed before the potential of this intervention can be translated for clinical use..
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:0890-8567
1527-5418
DOI:10.1016/j.jaac.2021.10.017